Larvol Delta - FID007003-FID007-and-Cetuximab-in-Treating-Patients-With-Advanced-Head-and-Neck-Squamous-Cell-Carcinoma

nanoencapsulated paclitaxel (FID-007) - ANP Technologies, Fulgent Genetics

Erbitux (cetuximab) - Eli Lilly

paclitaxel - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT06332092

Mar 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next